Evidence map›Paper›PMID 39634425›Full record

ArticleHeliyon2024

Deep learning-driven macroscopic AI segmentation model for brain tumor detection via digital pathology: Foundations for terahertz imaging-based AI diagnostics.

Myeong Suk Yim, Yun Heung Kim, Hyeon Sang Bark, Seung Jae Oh, Inhee Maeng, Jin-Kyoung Shim, Jong Hee Chang, Seok-Gu Kang, Byeong Cheol Yoo, Jae Gwang Kwon and 7 more

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Myeong Suk YimGimhae Biomedical Center, Gimhae Biomedical Industry Promotion Agency (GBIA), Gimhae, 05969, Republic of Korea.
Yun Heung KimDX Business Division, Deepnoid.Inc, Seoul, 08376, Republic of Korea.
Hyeon Sang BarkAdvanced Photonics Research Institute (APRI), Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea.
Seung Jae OhYUHS-KRIBB Medical Convergence Research Institute, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
Inhee MaengYUHS-KRIBB Medical Convergence Research Institute, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
Jin-Kyoung ShimDepartment of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
Jong Hee ChangDepartment of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
Seok-Gu KangDepartment of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
Byeong Cheol YooDX Business Division, Deepnoid.Inc, Seoul, 08376, Republic of Korea.
Jae Gwang KwonAdvanced Photonics Research Institute (APRI), Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea.
Jungsup ByunGimhae Biomedical Center, Gimhae Biomedical Industry Promotion Agency (GBIA), Gimhae, 05969, Republic of Korea.
Woon-Ha YeoDepartment of Artificial Intelligence Convergence, Sahmyook University, Seoul, 01795, Republic of Korea.
Seung-Hwan JungDepartment of Artificial Intelligence Convergence, Sahmyook University, Seoul, 01795, Republic of Korea.
Han-Cheol RyuDepartment of Artificial Intelligence Convergence, Sahmyook University, Seoul, 01795, Republic of Korea.
Se Hoon KimDepartment of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
Hyun Ju ChoiDX Business Division, Deepnoid.Inc, Seoul, 08376, Republic of Korea.
Young Bin JiAdvanced Photonics Research Institute (APRI), Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We used deep learning methods to develop an AI model capable of autonomously delineating cancerous regions in digital pathology images (H&E-stained images). By using a transgenic brain tumor model derived from the TS13-64 brain tumor cell line, we digitized a total of 187 H&E-stained images and annotated the cancerous regions in these images to compile a dataset. A deep learning approach was executed through DEEP:PHI, which abstracts Python coding complexities, thereby simplifying the execution of AI training protocols for users. By employing the Image Crop with Mask technique and patch generation method, we not only maintained an appropriate data class balance but also overcame the challenge of limited computing resources. This approach enabled us to successfully develop an AI training model that autonomously segments cancerous areas. This AI model enables the provision of guiding images for determining cancerous areas with minimal assistance from neuropathologists. In addition, the high-quality, large dataset curated for training using the proposed approach contributes to the development of novel terahertz imaging-based AI cancer diagnosis technologies and accelerates technological advancements.

Identifiers

PMID39634425
PMCPMC11616600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.